Tirzepatide as a therapeutic tool for kidney impairment in obesity: insights from a real-world study.

Galasso M, Verde L, Patrone R, Ragozzino G, Annunziata G, Colao A, Barrea L, Muscogiuri G

Open source

DOI
10.1186/s12967-026-08558-4
Published
2026 Jul 16
Container
Journal of translational medicine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12967-026-08558-4,
  title = {Tirzepatide as a therapeutic tool for kidney impairment in obesity: insights from a real-world study.},
  author = {Galasso M and Verde L and Patrone R and Ragozzino G and Annunziata G and Colao A and Barrea L and Muscogiuri G},
  year = {2026},
  journal = {Journal of translational medicine},
  doi = {10.1186/s12967-026-08558-4},
  url = {https://doi.org/10.1186/s12967-026-08558-4}
}

RIS

TY  - JOUR
TI  - Tirzepatide as a therapeutic tool for kidney impairment in obesity: insights from a real-world study.
AU  - Galasso M
AU  - Verde L
AU  - Patrone R
AU  - Ragozzino G
AU  - Annunziata G
AU  - Colao A
AU  - Barrea L
AU  - Muscogiuri G
PY  - 2026
JO  - Journal of translational medicine
DO  - 10.1186/s12967-026-08558-4
UR  - https://doi.org/10.1186/s12967-026-08558-4
ER  - 

APA

M, G., L, V., R, P., G, R., G, A., A, C., L, B., & G, M. (2026). Tirzepatide as a therapeutic tool for kidney impairment in obesity: insights from a real-world study.. Journal of translational medicine. https://doi.org/10.1186/s12967-026-08558-4

Source records